Immunovia ABIMMNOV 
$0.09-23.60%24h
-23.60%24h
Global rank
Market cap$3.91M
Change 7d15.67%
YTD Performance-46.52%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Immunovia AB (IMMNOV)
As of December 2024, Immunovia AB has a market cap of $3.91M. This makes Immunovia AB the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Immunovia AB from 2015 to 2024
-
Value:-
Market cap history of Immunovia AB from 2015 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $6.54M | -10.05% |
| 2023 | $7.27M | -93.26% |
| 2022 | $107.90M | -64.93% |
| 2021 | $307.70M | -37.08% |
| 2020 | $489.04M | -33.63% |
| 2019 | $736.84M | 30.33% |
| 2018 | $565.35M | 57.04% |
| 2017 | $360.01M | -4.62% |
| 2016 | $377.44M | 170.63% |
| 2015 | $139.47M | - |
IMMNOV Market Cap Today is $3.91M -23.60% - 22 Dec 2024
View largest stocks by market cap 
